Sunshine Biopharma Inc Warrant
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $9,594 | $9,594 | $8,435 | $9,303 |
Gross Profit | 3,093 | 3,093 | 2,866 | 2,305 |
EBITDA | -2,213 | -917 | -786 | |
EBIT | -2,278 | -982 | -837 | |
Net Income | -2,158 | -2,158 | -1,197 | -494 |
Net Change In Cash | 9,594 | 9,594 | 8,435 | 9,303 |
Free Cash Flow | -3,846 | -3,846 | -1,877 | -5,150 |
Cash | 9,686 | 9,686 | 12,206 | 11,507 |
Basic Shares | 2,580 | 1,267 | 49 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $34,874 | $24,092 | $4,345 | $228 |
Gross Profit | 10,669 | 8,339 | 1,696 | 110 |
EBITDA | -5,154 | -3,824 | -26,446 | -12,094 |
EBIT | -5,377 | -3,973 | -26,471 | -12,107 |
Net Income | -5,134 | -4,506 | -26,744 | -12,765 |
Net Change In Cash | 34,874 | 24,092 | 4,345 | 228 |
Free Cash Flow | -12,531 | -9,563 | -5,553 | -1,829 |
Cash | 9,686 | 16,292 | 21,826 | 2,045 |
Basic Shares | 701 | 12 | 7 | 1 |
